Articles Archives - Page 129 of 714

TuesdayOct 17, 2023 9:45 am

Pest Control Innovator SenesTech Inc. (NASDAQ: SNES) Offers Unique Solution to Tackle the Spread of Rats Amid Growing Health Concerns

SenesTech Inc. is building worldwide influence as a rat population control solution that humanely and cost-effectively based on fertility control The company’s trademarked ContraPest(R) brand is designed to target rat pest populations large and small, as well as hard-to-get roof rodents, and is the only EPA-registered rat contraception product for both male and female rats The rebound in rat populations worldwide in the wake of the COVID pandemic and a recent report on the spread of the rat lungworm parasite (which can sicken or kill humans) have fostered a new sense of concern about rat-carried diseases SenesTech is expanding its…

TuesdayOct 17, 2023 9:00 am

SOHM, Inc. (SHMN) Bolsters Executive Team; Confident About Anticipated Developments and Opportunities

SOHM just announced the appointment of Wm. Dewey Rushing as the new VP-Quality His appointment follows the recent nomination of Dr. Krishna Bhat as the new Chief Medical Advisor and Dr. David Aguilar as the new COO It also follows the recently signed LOI for SOHM to acquire ABBIE stem cell disruptive technology and patents from CGA Intellectual Holdings Inc. SOHM (OTC: SHMN), a generic drug manufacturing and distributing innovator, is bolstering its executive team as it eyes the global nutraceuticals market, which is expected to post a CAGR of 9.4% between 2023 and 2030, and the global NSAID market…

MondayOct 16, 2023 12:00 pm

PaxMedica Inc. (NASDAQ: PXMD) Announces Gold Sponsorship for The BRAIN Foundation’s Synchrony Symposia 2023

The BRAIN Foundation's Synchrony Symposia is the first and only international symposium on translational research for Autism Spectrum Disorder (“ASD”) PaxMedica Chairman and CEO Howard Weisman says that participating at the symposium is pivotal in advancing and fostering autism research As a Gold Sponsor, PaxMedica will have purview to the symposium’s interdisciplinary discussions, insights, and research presentations, clinical roundtables, mentor-mentee sessions, and more PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of Autism Spectrum Disorder (“ASD”) and other serious conditions with intractable neurologic symptoms, recently announced its Gold Sponsorship…

MondayOct 16, 2023 11:15 am

Clene Inc. (NASDAQ: CLNN) Applies Patented Nanotechnology to Development of CNM-Au8(R), its Investigational Drug for ALS

In line with recent emphasis on the growing importance of nanotechnology in the US, Clene Nanomedicine innovated its investigational drug, CNM-Au8(R), using nanotechnology for the treatment of neurodegenerative disease Clene’s nanotechnological approach was recently recognized by the NINDS of NIH with a substantial grant to conduct an Expanded Access Protocol in ALS with CNM-Au8(R) Clene aims to file a New Drug Application for CNM-Au8(R) for ALS indications in the first half of 2024 October 2023 has turned into a month for the celebration of nanotechnology. On Wednesday, Oct. 4, 2023, three U.S.-based scientists, Moungi Bawendi, Louis Brus, and Aleksey Ekimov,…

MondayOct 16, 2023 10:30 am

Electronic Servitor Publication Network Inc. (XESP) Uses the Power of their Intelligent Interactive Platform to Help Clients Build and Retain Revenue

Digital engagement innovator Electronic Servitor Publication Network is devoted to using advanced automated, interactive technological solutions to help clients build their businesses and retain customers through powerful and cost-effective customer engagement The global customer engagement solutions market is expected to grow at a CAGR of 10.8 percent between 2022 and 2027, with a value of $32.2 billion, according to Customer Engagement Solutions Market analysis Electronic Servitor Publication Network bases its growth-as-a-service managed offering on its proprietary Digital Engagement Engine(TM) technology, which provides customer-tailored content, data analysis, niche identification, and prompt responsiveness The trending nature of advanced conversational intelligence has granted…

MondayOct 16, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Ongoing Diabetes Study Program to Examine its Patented DehydraTECH(TM) Technology with Launch of Human and Animal Studies for Oral GLP-1 Drugs

Lexaria recently announced its intention to launch new human and animal studies exploring its patented DehydraTECH(TM) technology on GLP-1 drugs for the potential treatment of diabetes The studies will build on what Lexaria has achieved so far since it started its diabetes-related studies in 2022 Its DehydraTECH-CBD demonstrated an almost three-fold improvement in drug delivery into the blood in its DIAB-A22-1 diabetes study compared to the DehydraTECH-CBD formulation used in its HYPER-H21-4 hypertension study These studies follow Lexaria’s announcement of its intention to study weight loss and diabetes control in a human population using DehydraTECH Lexaria Bioscience (NASDAQ: LEXX), a…

MondayOct 16, 2023 9:00 am

Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) Makes Significant Steps in Cementing Its Position among Top Critical Mineral Explorers with PCH Project

Appia recently entered into a definitive agreement to acquire up to a 70% interest in the 17,551.07-hectare PCH Project located in the State of Goiás, Brazil The company completed a due diligence program, with the initial results confirming widespread REE enrichment across the property Total rare earth element (“REE”) grades in numerous auger holes drilled at Target 4 ranged from 274 parts per million (“ppm”) to 16,648 ppm (1.66%), with an average of 1,291 ppm total REE, the results showed The PCH Project has a relatively higher content of heavy REE (“HREE”) in the deposit than Serra Verde, a large…

FridayOct 13, 2023 10:30 am

Last Change to Register for the 2023 New Orleans Investment Conference

Serious investors — and anyone concerned with protecting and building wealth in volatile times — invited to attend the New Orleans Investment Conference to be held in New Orleans, November 1-4, 2023. With a rich legacy spanning almost 50 years, the New Orleans Investment Conference has been acclaimed as “The Greatest Investment Show on Earth” by Money Magazine. Held in the heart of New Orleans, the 2023 Conference is set to present a dream team of world-class experts on geopolitics, macroeconomics and every asset class to hundreds of savvy investors. The 2023 Conference will feature enlightening presentations from leading experts…

FridayOct 13, 2023 9:45 am

GolfLync Inc. Surpasses 75,000 Members, Marking Monumental Growth for Golfing Community Across the United States

GolfLync's members embrace innovative features, including organizing tee times, sharing golf experiences, hosting events, and building lasting connections with like-minded enthusiasts The GolfLync app facilitates connections based on location and personal preferences on the course – making tee times more enjoyable and easier to facilitate The global golf club market is expected to grow at a CAGR of 2.5%, resulting in a value of $4.45 billion by 2027 GolfLync, one of the hottest and fastest-growing social networking platforms for golf enthusiasts, has announced that enrollment has surpassed 75,000 members across the United States. This monumental growth underscores the company's mission…

FridayOct 13, 2023 9:00 am

SenesTech Inc. (NASDAQ: SNES) Eager to Work with Cities to Address Rat Crises Using Effective Fertility-Restricting Method

SenesTech pioneered an innovative rat control method that restricts the fertility of both male and female rats, ContraPest(R) With cities around the country and the world, in general, implementing a raft of rat control methods, SenesTech is eager to work with city governments to address the rat crises Rat populations are surging in many major cities, driven by the post-COVID rebound in business and climate change Studies show that ContraPest can reduce rat populations by more than 90% and sustain the reduced numbers, when added to an integrated pest management plan Once threatened by the sudden COVID-induced closure of businesses…

Site Search

Company Search

Category: Articles